Prodisc® C Vivo and Prodisc® C Cervical NOVA Total DISC of replacement (TDR) are now certified and marked with CE according to the regulation of EU medical devices (MDR), the highest European level of quality, safety and performance for medical devices.
The Vivo and Prodisc C Nova Match-The-Disc ™ system is the first and only cervical TDR system with two different MDR certified devices.
Prodisc C vivo and Prodisc C Nova have been in internationally clinical use since 2009 and, together, are one of the most used cervical TDR systems in the world.
West Chester, Pa., September 11, 2025 / Prnewswire / -Centinel Spine®, LLC (“The Company”), the global company of global medical devices focused exclusively on treat Produc-CDISCS certification certification for Producc C. Total Cervical Nova Disco Replacement Systems. The achievement underlines Centinel Spine’s commitment to provide safe and high quality proven products.
The company has successfully completed the registration and certification process for its main international Cervical TDR products according to the new MDR of the European Union. Total DiscC C Vivo and Prodisc C Nova Cervical replacement systems are now compatible and marked with CE according to the highest European standards of quality, safety and performance for medical devices. The MDR certification guarantees that medical devices are safe and meet the latest strict regulatory requirements of the European Union.
Speaking about the MDR certification, Prof. Dr. Christoph Mehren, head of the Spinal Surgery Department of the Schön Klinik hospital in Münich, Germany, declared: “The path to MDR’s approval is extremely challenging. The distant future was extremely important for me and the resulting care I can provide to my patients.”
The CEO of Centinel Spine, Steve Murray, adds: “This marks a fundamental moment for Centinel Spine as an organization. Ensure the MDR certification for the Prodisc C vivo and Prodisc C Nova Total DISC of replacement devices has been a complex and demanding process, but underlines our vision of commitment of life. Throughout the world by expanding access to Prodisc technologies.
Prodisc C vivo and Prodisc C Nova have been in internationally clinical use since 2009 and, together, are one of the most used TDR systems in the world. The Vivo Prodisc C device offers insertion without keel and combines a superior final design of anatomically designed anatomically designed with lateral peaks to optimize the adjustment and provide an immediate fixation. The Prodisc C Nova device presents a flat final plaque designed to coincide better with the flat vertebral anatomy, along with a unique TRI-K design to offer an immediate fixation. Both devices incorporate Core Primisc technology, the basis behind the predictable clinical results of each Prodisc device after more than 35 years and 275,000 implantations, worldwide.*
* Data in the file in Centinel Spine
About Centinel Spine, LLC
Centinel Spine®, LLC is the global company of global medical devices centered exclusively on addressing cervical and lumbar spinal disease with Prodisc®, the most complete disc replacement technology platform (TDR) in the world.
The company’s Prodisc technology is the most studied and clinically tested TDR system worldwide, validated by more than 540 published articles and more than 275,000 implantations. The Primisc de Centinel Spine is the only TDR technology with multiple anatomical solutions to preserve movement, allowing the surgeon to coincide with the anatomy of each patient for the replacement of a total cervical and lumbar disk.
For more information, visit the company’s website at www.centinelspine.com or communicate with:
Varun Gandhi
Financial Director
900 Airport Road, Suite 3b
West Chester, Pa 19380
Telephone: 484-887-8871
Email: v.gandhi@centinelspine.com
Source of Centinel Spine, LLC
